Trifănescu, O.G.; Mitrea, D.; Galeș, L.N.; Ciornei, A.; Păun, M.-A.; Butnariu, I.; Trifănescu, R.A.; Motaș, N.; Toma, R.V.; Bîlteanu, L.;
et al. Therapies beyond Physiological Barriers and Drug Resistance: A Pilot Study and Review of the Literature Investigating If Intrathecal Trastuzumab and New Treatment Options Can Improve Oncologic Outcomes in Leptomeningeal Metastases from HER2-Positive Breast Cancer. Cancers 2023, 15, 2508.
https://doi.org/10.3390/cancers15092508
AMA Style
Trifănescu OG, Mitrea D, Galeș LN, Ciornei A, Păun M-A, Butnariu I, Trifănescu RA, Motaș N, Toma RV, Bîlteanu L,
et al. Therapies beyond Physiological Barriers and Drug Resistance: A Pilot Study and Review of the Literature Investigating If Intrathecal Trastuzumab and New Treatment Options Can Improve Oncologic Outcomes in Leptomeningeal Metastases from HER2-Positive Breast Cancer. Cancers. 2023; 15(9):2508.
https://doi.org/10.3390/cancers15092508
Chicago/Turabian Style
Trifănescu, Oana Gabriela, Dan Mitrea, Laurenția Nicoleta Galeș, Ana Ciornei, Mihai-Andrei Păun, Ioana Butnariu, Raluca Alexandra Trifănescu, Natalia Motaș, Radu Valeriu Toma, Liviu Bîlteanu,
and et al. 2023. "Therapies beyond Physiological Barriers and Drug Resistance: A Pilot Study and Review of the Literature Investigating If Intrathecal Trastuzumab and New Treatment Options Can Improve Oncologic Outcomes in Leptomeningeal Metastases from HER2-Positive Breast Cancer" Cancers 15, no. 9: 2508.
https://doi.org/10.3390/cancers15092508
APA Style
Trifănescu, O. G., Mitrea, D., Galeș, L. N., Ciornei, A., Păun, M.-A., Butnariu, I., Trifănescu, R. A., Motaș, N., Toma, R. V., Bîlteanu, L., Gherghe, M., & Anghel, R. M.
(2023). Therapies beyond Physiological Barriers and Drug Resistance: A Pilot Study and Review of the Literature Investigating If Intrathecal Trastuzumab and New Treatment Options Can Improve Oncologic Outcomes in Leptomeningeal Metastases from HER2-Positive Breast Cancer. Cancers, 15(9), 2508.
https://doi.org/10.3390/cancers15092508